Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month […]